Canopy Growth Corp SEC filings CGC
Canopy Growth Corp has 763 filings in SEC EDGAR's recent list, going back to May 16, 2018. Its latest annual report, Form ARS, was filed on Aug 7, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (shareholder vote results). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| EFFECT | Filing | Feb 13, 2026 | — |
| CORRESP | Letter to the SEC | Feb 12, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2026 | — |
| EFFECT | Filing | Jan 15, 2026 | — |
| CORRESP | Letter to the SEC | Jan 13, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2026 | — |
| EFFECT | Filing | Jun 4, 2025 | — |
| POSASR | Filing | May 29, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 21, 2025 | — |
| EFFECT | Filing | Jun 17, 2024 | — |
| EFFECT | Filing | Jun 17, 2024 | — |
| EFFECT | Filing | Jun 17, 2024 | — |
| EFFECT | Filing | Jun 17, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 29, 2024 | — |
| EFFECT | Filing | May 13, 2024 | — |
| CORRESP | Letter to the SEC | May 10, 2024 | — |
| UPLOAD | Letter from the SEC | May 10, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2024 | — |
| EFFECT | Filing | Feb 5, 2024 | — |
| CORRESP | Letter to the SEC | Feb 5, 2024 | — |
| PRER14A | Filing | Feb 5, 2024 | — |
| CORRESP | Letter to the SEC | Feb 1, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 31, 2024 | — |
| CORRESP | Letter to the SEC | Jan 25, 2024 | — |
| PRER14A | Filing | Jan 25, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2023 | — |
| EFFECT | Filing | Sep 26, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2023 | — |
| CORRESP | Letter to the SEC | Sep 22, 2023 | — |
| EFFECT | Filing | Sep 8, 2023 | — |
| CORRESP | Letter to the SEC | Sep 6, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| CORRESP | Letter to the SEC | Aug 11, 2023 | — |
| PRER14A | Filing | Aug 11, 2023 | — |
| EFFECT | Filing | Jul 28, 2023 | — |
| CORRESP | Letter to the SEC | Jul 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2023 | — |
| NT 10-K/A | Filing | Jun 14, 2023 | Mar 31, 2023 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| NT 10-K | Filing | May 26, 2023 | Mar 31, 2023 |
| CORRESP | Letter to the SEC | May 22, 2023 | — |
| PRER14A | Filing | May 22, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2023 | — |
| PRER14A | Filing | Jan 17, 2023 | — |
| CORRESP | Letter to the SEC | Jan 13, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2022 | — |
| CORRESP | Letter to the SEC | Dec 12, 2022 | — |
| PRER14A | Filing | Dec 12, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2022 | — |
| CORRESP | Letter to the SEC | Feb 16, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2022 | — |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2021 | — |
| CERT | Filing | Nov 17, 2020 | — |
| CERT | Filing | Nov 13, 2020 | — |
| 25/A | Filing | Nov 13, 2020 | — |
| 8-A12B/A | Filing | Nov 13, 2020 | — |
| 25 | Filing | Nov 13, 2020 | — |
| 8-A12B | Filing | Nov 13, 2020 | — |
| SC TO-I/A | Filing | Dec 6, 2018 | — |
| SC TO-I | Filing | Nov 2, 2018 | — |
| CERT | Nyse certification - canopy growth corp | May 22, 2018 | — |
| 40FR12B | Filing | May 16, 2018 | — |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- CGC (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Smith Falls, Ontario, Canada
- SEC filer status
- Accelerated filer
- SEC CIK
- 1737927
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.